Results
|
|
22141.
|
|
|
|
22142.
|
|
|
|
22143.
|
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days. [electronic resource] by
- Wall, J G
- Burris, H A
- Von Hoff, D D
- Rodriguez, G
- Kneuper-Hall, R
- Shaffer, D
- O'Rourke, T
- Brown, T
- Weiss, G
- Clark, G
Producer: 19921207
In:
Anti-cancer drugs vol. 3
Availability: No items available.
|
|
|
22144.
|
|
|
|
22145.
|
|
|
|
22146.
|
|
|
|
22147.
|
|
|
|
22148.
|
|
|
|
22149.
|
|
|
|
22150.
|
|
|
|
22151.
|
|
|
|
22152.
|
|
|
|
22153.
|
|
|
|
22154.
|
|
|
|
22155.
|
|
|
|
22156.
|
|
|
|
22157.
|
|
|
|
22158.
|
|
|
|
22159.
|
|
|
|
22160.
|
|